Revance Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/14/2025
Shares
1,413,103
Value ($000)
4,296
Weight
0.1%
2024 Q3 - 2024 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).